Abstract
Endometrial cancer is the most common gynaecological malignancy encountered in developed countries and the second most common in the developing world. The five-year survival rate of patients with endometrial cancer diagnosed at a late stage is <30%. Therefore, it is critical to develop a suitable chemotherapeutic regimen for late-stage endometrial cancer. Cisplatin (CDDP) is a first-line chemotherapeutic drug for endometrial cancer chemotherapy. The present study investigated the molecular mechanism underlying the effect of CDDP on endometrial cancer from the perspective of cell autophagy. Ishikawa cells were treated with 10, 20, 40 or 80 µg/ml CDDP for 12, 24, 48 and 72 h. The cells were then harvested and subjected to cell proliferation assays. Based on the results, 20 µg/ml CDDP was selected as the treatment used for 12 and 24 h for the assays. To detect the effect of CDDP on Ishikawa cell autophagy, autophagosome formation was observed using a transmission electron microscope, and the expression level of autophagy-related gene microtubule-associated protein 1 light chain 3α, was examined using immunofluorescence microscopy. The results demonstrated that CDDP treatment promoted cell autophagy in Ishikawa cells. In addition, ...Continue Reading
References
Aug 24, 1999·American Journal of Obstetrics and Gynecology·J F MagrinaJ L Cornella
Dec 2, 2000·Science·D J Klionsky, S D Emr
Jan 5, 2002·Cancer Chemotherapy and Pharmacology·R D DeHaanD L Persons
Feb 1, 2005·Cell·Julian J LumCraig B Thompson
Jan 15, 2008·Cell·Beth Levine, Guido Kroemer
May 24, 2008·Autophagy·Gur P KaushalCheng Yang
Aug 5, 2008·Cancer Research·Yanlin JiangMark R Kelley
Aug 27, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Eileen White, Robert S DiPaola
Mar 2, 2010·Cancer Biotherapy & Radiopharmaceuticals·Jing-Hua RenGang Wu
Aug 18, 2010·Antioxidants & Redox Signaling·Isei Tanida
Feb 8, 2011·CA: a Cancer Journal for Clinicians·Ahmedin JemalDavid Forman
Jun 21, 2012·Biochemical and Biophysical Research Communications·Ning XuQiang Xia
Jul 10, 2012·American Journal of Otolaryngology·Rong KangShu-Xin Wen
Oct 20, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Brian M Slomovitz, Robert L Coleman
Jul 3, 2013·Seminars in Cancer Biology·János KubischTamás Korcsmáros
Jul 25, 2013·Pathology, Research and Practice·Yongshun ChenBo Tan
Apr 17, 2014·Current Medicinal Chemistry·Jiezhong ChenChen Chen
Jul 25, 2014·European Journal of Pharmacology·Shaloam Dasari, Paul Bernard Tchounwou
Jun 17, 2015·Journal of Cancer·Ruolin ZhaoKunfu Zhou
Aug 27, 2015·International Journal of Pediatric Otorhinolaryngology·Cha Kyung YounSung Il Cho
Aug 28, 2015·Oncotarget·Jen-Pi TsaiYi-Hsien Hsieh
Sep 10, 2015·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Fangjuan DuMaowu Yang
Sep 10, 2015·Cellular and Molecular Neurobiology·Ya-Ping LiuDian-Shuai Gao
Sep 10, 2015·Oncology Reports·Uddin Md Nazim, Sang-Youel Park
Apr 12, 2016·Cancer Cell International·Yongli ZhangXiaoping Wan
Jun 30, 2016·Drug Design, Development and Therapy·Haiyan ZhuXueqiong Zhu
Citations
Jul 10, 2019·International Journal of Molecular Sciences·Can CaoYan Zhu
Dec 10, 2019·Anti-cancer Agents in Medicinal Chemistry·Yingying ChenMingqi Tan
Jun 30, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Yingying ZhuGuixing Ren
Aug 12, 2018·International Journal of Molecular Sciences·Tom Van NyenFrédéric Amant
May 14, 2020·Autophagy·Laura Devis-JaureguiDavid Llobet-Navàs
Oct 8, 2020·Cell Death Discovery·Ming JinYuan Li
Feb 10, 2021·Cell Death & Disease·Aniketh BishnuPritha Ray
Feb 10, 2021·Cell Biology International·Qin LiZhao Ma
Apr 21, 2021·Reproductive Sciences·Pooja PopliRamakrishna Kommagani
Jul 23, 2021·BMC Cancer·Aizhi GengXue Gao
May 13, 2019·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Qiongyan LinQingping Jiang